All News

Hememics Biotechnologies, Inc. Announces Successful Close in $2 Million Seed 2 Financing from TEDCO and Qualified Investors to Accelerate Growth

Biosensors for on-the-spot tests: Two companies plan to debut new tech for COVID-19 testing by year's end

U. S. cities pilot connected-vehicle tech: Enabling conventional vehicles to communicate could save lives right now

Company: New coronavirus test could diagnose the virus in 60 seconds or less

BARDA to work with Hememics on rapid COVID-19 test

Hememics’ rapid point-of-care COVID-19 test gets infusion from BARDA

HEMEMICS Biotechnologies, Inc. Receives HHS Support to Develop Rapid Antigen, Antibody Diagnostic to Identify COVID-19 Infected Americans

Inova Personalized Health Accelerator Accepts HeMemics Biotechnologies, Inc. into Portfolio

Hememics Biotechnologies Inc. Received $2.5 Million Investment from AMVI Partners